T1	Participants 388 514	Injection drug users (IDUs) seeking substance abuse treatment between the ages of 18 and 50 years who were addicted to opioids
T2	Participants 1147 1255	Among the 125 patients who enrolled in the study, 57 selected clonidine and 68 selected clonidine/naltrexone
T3	Participants 1003 1032	nonrandomized clinical trial.
T4	Participants 1261 1277	treatment groups
